Hepatitis C Virus Inhibits Cell Surface Expression of HLA-DR, Prevents Dendritic Cell Maturation, and Induces Interleukin-10 Production - sprookjes - yvandenbroek - TriplyDB

Hepatitis C Virus Inhibits Cell Surface Expression of HLA-DR, Prevents Dendritic Cell Maturation, and Induces Interleukin-10 Production

Hepatitis C Virus Inhibits Cell Surface Expression of HLA-DR, Prevents Dendritic Cell Maturation, and Induces Interleukin-10 Production

http://www.wikidata.org/entity/Q27485530

about

Dendritic cell-based immunity and vaccination against hepatitis C virus infection Influence of HIV and HCV on T cell antigen presentation and challenges in the development of vaccines Viruses in cancer cell plasticity: the role of hepatitis C virus in hepatocellular carcinoma Success of antiviral therapy in chronic hepatitis C infection relates to functional status of myeloid dendritic cells Hepatitis C Virus Core Protein Augments Androgen Receptor-Mediated Signaling Differential Effects of Hepatitis C Virus JFH1 on Human Myeloid and Plasmacytoid Dendritic Cells Influence of dendritic cells on viral pathogenicity Innate immune function in placenta and cord blood of hepatitis C--seropositive mother-infant dyads.Early IL-10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users.NK cells, innate immunity and hepatitis C infection after liver transplantation.Transcriptional repression of C4 complement by hepatitis C virus proteins.Role of host genetic factors in the outcome of hepatitis C virus infection.Oncogenic potential of hepatitis C virus proteins Cowpox virus induces interleukin-10 both in vitro and in vivo New insights into type I interferon and the immunopathogenesis of persistent viral infections.Hepatitis C virus infection: establishment of chronicity and liver disease progression Study of human B7 homolog 1 expression in patients with hepatitis B virus infection Hepatitis C virus-mediated inhibition of cathepsin S increases invariant-chain expression on hepatocyte surface.Dendritic cells, regulatory T cells and the pathogenesis of chronic hepatitis C.Noncanonical dendritic cell differentiation and survival driven by a bacteremic pathogen.Hepatitis C virus induces interleukin-1β (IL-1β)/IL-18 in circulatory and resident liver macrophages.Divergent contributions of regulatory T cells to the pathogenesis of chronic hepatitis C The affect of chronic hepatitis C infection on dendritic cell function: a summary of the experimental evidence.Dendritic cells in the pathogenesis and treatment of human diseases: a Janus Bifrons?Developments in virus-like particle-based vaccines for infectious diseases and cancer.Natural killer cells in hepatitis C virus infection.Viral (hepatitis C virus, hepatitis B virus, HIV) persistence and immune homeostasis.Involvement of TLR2-MyD88 in abnormal expression of miR-146a in peripheral blood monocytes of patients with chronic hepatitis C.Viral evasion and challenges of hepatitis C virus vaccine development.Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection.IL-10: A Multifunctional Cytokine in Viral Infections.Immune Evasion Strategies during Chronic Hepatitis B and C Virus Infection Dysfunction of autophagy participates in vacuole formation and cell death in cells replicating hepatitis C virus.Immunomodulation by hepatitis C virus-derived proteins: targeting human dendritic cells by multiple mechanisms.Indolamine 2,3-dioxygenase expression by monocytes and dendritic cell populations in hepatitis C patients.Hepatitis C virus modulates human monocyte-derived dendritic cells Coevolution of the hepatitis C virus polyprotein sites in patients on combined pegylated interferon and ribavirin therapy.Immunotherapy of hepatocellular carcinoma: Unique challenges and clinical opportunities.Induction of antitumor immunity ex vivo using dendritic cells transduced with fowl pox vector expressing MUC1, CEA, and a triad of costimulatory molecules (rF-PANVAC).Human dendritic cells expressing hepatitis C virus core protein display transcriptional and functional changes consistent with maturation.

P2860

Q26828003-342745D0-5D2D-4A17-8793-1D006D161736 Q26999264-09555EBB-71D0-4A3A-A961-8212E409F240 Q27012614-84A4E6EF-FAE8-4C03-9828-8125B3D9EB59 Q27023059-822FBA35-EC8F-40A9-9455-21B556AC5A38 Q27487140-504FFC8A-B6E0-4F48-8030-9C97F2C893B9 Q27488392-5625475C-AA61-4436-970B-B3A50FDD8E1C Q33489629-3E4F1A6B-49F3-4046-BC67-4620A63B2368 Q34073021-A58A2749-A74A-4E61-95DD-3BF72562FFE8 Q34777709-5D0E5F37-5F21-49CA-97C4-3A0261AE4B2B Q35019869-AC7254D5-8ABC-4666-B87A-66D2144B3379 Q35076923-FC35A4C1-07F7-488C-B98E-1D9FCB2EB378 Q35259735-34A47512-8D89-47BF-B687-99F870DC68E4 Q35261292-9CF38D71-3973-42CE-A121-E9646C6ACB3A Q35539329-F45FA0F0-9B27-4012-B5B9-68DB838A82F7 Q35648751-80897ABC-68DD-4690-9199-47C55B033D91 Q35728873-ED01BE6C-690C-41B2-8DC0-B2AB08888986 Q36121216-702236B7-1F20-4EBF-A642-C01676018BFC Q36246195-31E71D34-218C-4C99-8739-72780959BB78 Q36535789-2C239473-F9E9-4762-A7C6-47CC3C42D628 Q37022848-4E434745-EBDA-482D-A09A-7BB7D440F8BE Q37254259-FECD0EAF-A0B7-4B9B-9E76-131659BF6273 Q37683126-0A8E3CE6-017B-4485-AAB7-6544DA0BC45C Q37906779-BBDB57C2-E0C5-498F-A101-313426FE508E Q37945301-3FB0085A-AFD5-426F-8A97-AB71B71FC042 Q37951525-1932ACBE-D2E8-4152-A17C-947DFB24A026 Q38061192-AF101B57-D202-4C73-ABB7-71156675228B Q38223279-6322C08C-0DB0-41B5-8F3F-6B5A1B1384BC Q38886770-FCC4EAA8-077E-40D5-BF16-958C3121ED1F Q38961608-E3C60967-3E28-461C-A9F2-AA6167D630C0 Q39000980-E280D3FE-AF26-4207-8BE7-CD1E698D0AB3 Q39186731-6F5C7BF3-EBE4-4463-BA26-448075818AFB Q39327457-2AB6CE25-FAB2-4EE0-B059-51AC9DF15E35 Q39458949-F48ED0F7-A89B-403B-A9E6-DC306949FFAC Q39712175-BE2BE128-6546-4A72-8DF6-D5FCE9FAE08D Q41531461-4945752A-9159-4A61-8169-B7A3F21DB281 Q41785343-20575AEA-C673-431F-A415-23E96250DD1C Q41841986-1EC27606-0BD5-43EF-B05A-31E970BDAD19 Q42024872-F56459B4-7A5F-4D07-B3FD-BD2F3C4B2516 Q42089413-ECC86557-0BAA-41FA-8D53-4ACB28F37ADC Q42999171-E2C168B4-21BE-45EF-B51E-4E794C5A5496

P2860

Hepatitis C Virus Inhibits Cell Surface Expression of HLA-DR, Prevents Dendritic Cell Maturation, and Induces Interleukin-10 Production

http://www.wikidata.org/entity/Q27485530

description

2008 nî lūn-bûn

@nan

2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

name

Hepatitis C Virus Inhibits Cel ...... uces Interleukin-10 Production

@ast

Hepatitis C Virus Inhibits Cel ...... uces Interleukin-10 Production

@en

Hepatitis C Virus Inhibits Cel ...... uces Interleukin-10 Production

@nl

type

label

Hepatitis C Virus Inhibits Cel ...... uces Interleukin-10 Production

@ast

Hepatitis C Virus Inhibits Cel ...... uces Interleukin-10 Production

@en

Hepatitis C Virus Inhibits Cel ...... uces Interleukin-10 Production

@nl

prefLabel

Hepatitis C Virus Inhibits Cel ...... uces Interleukin-10 Production

@ast

Hepatitis C Virus Inhibits Cel ...... uces Interleukin-10 Production

@en

Hepatitis C Virus Inhibits Cel ...... uces Interleukin-10 Production

@nl

P1433

Q27485530-047867FD-2ACF-4674-B81A-1A4E67E2A3D2

P1476

Q27485530-5214A856-EC93-40DB-9C52-6FF4AE62F584

P2093

Q27485530-0B2E86C4-445D-437C-BC30-43CE2185A974

Q27485530-21ACA4ED-0D48-4543-9DAD-FC84AD52E6D8

Q27485530-3031FB81-2735-4E24-B78B-7D5D3FC5EADC

Q27485530-517A3E42-9B85-4B54-BDAC-43DF4B3511DA

Q27485530-65FC6759-D49B-47EE-9A44-90F2DCA78BD1

Q27485530-7FF8EF0C-424C-45B8-A4B2-9D9BE1E28BB1

Q27485530-CEA85205-320C-46B4-9731-0434AB2A717F

Q27485530-EAC5E32F-A672-4579-A50F-FB00DC716ADA

P2860

Q27485530-1A69CE41-EC24-47B8-AC36-335B0D51ED64

Q27485530-218FD05D-7D61-4905-89A1-3012B90CC904

Q27485530-25C4B233-CE36-413D-8652-EBDB1E4522FD

Q27485530-26B9908D-D153-4F04-88B8-5B9EEA126F6E

Q27485530-3636C61E-A5E3-4616-86CC-4F57BAD160E8

Q27485530-364AED7A-C576-414E-AE3F-9F11436CA46D

Q27485530-44B60B58-60ED-468C-862F-E46A8A7BEA7B

Q27485530-500D3575-52AF-4A8F-88FA-115C88CC6C26

Q27485530-5172795B-1402-4C2F-BE3E-0BACF4C51344

Q27485530-56EF874F-A7C9-4EA3-8E4F-B670516F522B

P304

Q27485530-AD427384-35EE-48E8-AA61-8B9A37B5872C

P31

Q27485530-E1906AE2-F2B5-485A-A715-DB4AC31BF51A

P356

Q27485530-EB6A7564-4379-4647-9CB7-B19E29AF594A

P433

Q27485530-61998C3D-7E0C-4A5D-834F-A5F7638CFAA4

P478

Q27485530-03C23A24-2BA6-4CF9-9089-3F6E4FCAE14B

P50

Q27485530-E89958C3-1A28-42B6-ACB6-C2E8E4422ABE

P577

Q27485530-ED497789-E9DD-444D-A44C-43E71ADC8580

P698

Q27485530-80A58D42-C979-49EF-BEA8-8FC4E75FFDB9

P921

Q27485530-b7a7edea-d294-4b0f-89e4-8017ad8f7ac8

P932

Q27485530-A2D6AFB3-99D6-4879-905C-3F48F200BADA

P356

P1433

Journal of Virology

P1476

Hepatitis C Virus Inhibits Cel ...... uces Interleukin-10 Production

@en

P2093

Azra Blazevic

http://www.w3.org/2001/XMLSchema#string

Daniel F Hoft

http://www.w3.org/2001/XMLSchema#string

Getahun Abate

http://www.w3.org/2001/XMLSchema#string

Keith Meyer

http://www.w3.org/2001/XMLSchema#string

Kousuke Saito

http://www.w3.org/2001/XMLSchema#string

Malika Ait-Goughoulte

http://www.w3.org/2001/XMLSchema#string

Ranjit Ray

http://www.w3.org/2001/XMLSchema#string

Steven M Truscott

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR

Viral immune evasion due to persistence of activated T cells without effector function

Generation of Infectious Hepatitis C Virus in Immortalized Human Hepatocytes

Expression of DC-SIGN and DC-SIGNR on Human Sinusoidal Endothelium

Dendritic Cell Function during Chronic Hepatitis C Virus and Human Immunodeficiency Virus Type 1 Infection

Hepatitis C Virus Structural Proteins Impair Dendritic Cell Maturation and Inhibit In Vivo Induction of Cellular Immune Responses

The bare lymphocyte syndrome and the regulation of MHC expression

MHC class II genes influence the susceptibility to chronic active hepatitis C

Mini-review: Specificity and expression of CIITA, the master regulator of MHC class II genes

Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application.

P304

3320-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.02547-07

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

82

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18216090

http://www.w3.org/2001/XMLSchema#string

P921

P932

2268470

http://www.w3.org/2001/XMLSchema#string